Kaviya Mohandass

Ms. Kaviya Mohandass

Research Scholar
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2021 in Molecules
Verified
Journal Article
Open access
PDF file
VAVijaya Anand Arumugam
Vijaya Anand Arumugam
Balamuralikrishnan BalasubramanianBalamuralikrishnan Balasubramanian
Balamuralikrishnan Balasubramanian
Kaviya MohandassKaviya Mohandass
Kaviya Mohandass
KBKathirvel Bharathi
Kathirvel Bharathi
APAluru Parithathvi
Aluru Parithathvi
Kuldeep DhamaKuldeep Dhama
Kuldeep Dhama
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome corona virus-2 (SARS-CoV-2), is the most important health issue, internationally. With no specific and effective antiviral therapy for COVID-19, new or repurposed antiviral are urgently needed. Phytochemicals pose a ray of hope for human health during this pandemic, and a great deal of research is concentrated on it. Phytochemicals have been used as antiviral agents against several viruses since they could inhibit several viruses via different mechanisms of direct inhibition either at the viral entry point or the replication stages and via immunomodulation potentials. Recent evidence also suggests that some plants and its components have shown promising antiviral properties against SARS-CoV-2. This review summarizes certain phytochemical agents along with their mode of actions and potential antiviral activities against important viral pathogens. A special focus has been given on medicinal plants and their extracts as well as herbs which have shown promising results to combat SARS-CoV-2 infection and can be useful in treating patients with COVID-19 as alternatives for treatment under phytotherapy approaches during this devastating pandemic situation.

14 February 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Kaviya MohandassKaviya Mohandass
Kaviya Mohandass
Balamuralikrishnan BalasubramanianBalamuralikrishnan Balasubramanian
Balamuralikrishnan Balasubramanian
KBKathirvel Bharathi
Kathirvel Bharathi
AMArun Kumar Malaisamy
Arun Kumar Malaisamy
NANaif Abdullah Al-Dhabi
Naif Abdullah Al-Dhabi
Wen-Chao LiuWen-Chao Liu
Wen-Chao Liu
Boerhavia diffusa L. Nyctanginaceae (B. diffusa) is a medicinal herb commonly considered as a weed. The exploration of phytochemicals in different parts of B. diffusa with different solvents will create awareness, along with the suitable solvent and method for extraction of pharmaceutical compounds. Hence, the present study focuses on phytochemical analysis of B. diffusa leaves, stems, and roots in various solvents with hot and cold extraction. The decoctions performed well in most of the qualitative and quantitative tests, along with the DPPH assay. The aqueous extract showed a good result in the FRAP assay and ABTS assay. In the antimicrobial test, the B. diffusa root ethanol extract inhibited the growth of Pseudomonas aeruginosa and Staphylococcus aureus with zones of inhibition of about 8 mm and 20 mm at 200 µg concentration, respectively. Using a molecular docking approach, the top four ranked molecules from the crude extract of B. diffusa profiled from GC–MS spectroscopy in terms of growth inhibition of the pathogenic bacterium P. aeruginosa were selected; among them, 2-(1,2 dihydroxyethyl)-5-[[2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydrochromen-6-yl]oxy]oxolane-3,4-diol exhibited the minimum binding score, revealing high affinity in complex. B. diffusa is highly nutritious, and the maceration and decoction extracts were similar except for the chloroform extract that was found to be weak.

1 January 2023 in Journal of the Renin-Angiotensin-Aldosterone System
Verified
Journal Article
Open access
PDF file
BNBalasundaram Nandhini
Balasundaram Nandhini
YSYacobu Sureshraj
Yacobu Sureshraj
Kaviya MohandassKaviya Mohandass
Kaviya Mohandass
TSThangavelu Sangeetha
Thangavelu Sangeetha
KBKathirvel Bharathi
Kathirvel Bharathi
VAVijaya Anand Arumugam
Vijaya Anand Arumugam
Thrombocytes (platelets) are the type of blood cells that are involved in hemostasis, thrombosis, etc. For the conversion of megakaryocytes into thrombocytes, the thrombopoietin (TPO) protein is essential which is encoded by the TPO gene. TPO gene is present in the long arm of chromosome number 3 (3q26). This TPO protein interacts with the c-Mpl receptor, which is present on the outer surface of megakaryocytes. As a result, megakaryocyte breaks into the production of functional thrombocytes. Some of the evidence shows that the megakaryocytes, the precursor of thrombocytes, are seen in the lungs interstitium. This review focuses on the involvement of the lungs in the production of thrombocytes and their mechanism. A lot of findings show that viral diseases, which affect the lungs, cause thrombocytopenia in human beings. One of the notable viral diseases is COVID-19 or severe acute respiratory syndrome caused by SARS-associated coronavirus 2 (SARS-CoV-2). SARS-CoV-2 caused a worldwide alarm in 2019 and a lot of people suffered because of this disease. It mainly targets the lung cells for its replication. To enter the cells, these virus targets the angiotensin-converting enzyme-2 (ACE-2) receptors that are abundantly seen on the surface of the lung cells. Recent reports of COVID-19-affected patients reveal the important fact that these peoples develop thrombocytopenia as a post-COVID condition. This review elaborates on the biogenesis of platelets in the lungs and the alterations of thrombocytes during the COVID-19 infection.

2 July 2020 in International Journal of Human Genetics
Verified
Journal Article
Closed access
Kaviya MohandassKaviya Mohandass
Kaviya Mohandass


1 March 2024 in Neurology Asia
Verified
Journal Article
Closed access
PMPradeepkumar Murugasamy
Pradeepkumar Murugasamy
GMGomathi Mohan
Gomathi Mohan
Kaviya MohandassKaviya Mohandass
Kaviya Mohandass